Immuneering Corp is a biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
IMRX is expected to report earnings to -44 cents per share on August 06
Q2'25
Est.
$-0.44
Q1'25
Beat
by $0.05
Q4'24
Missed
by $0.13
Q3'24
Beat
by $0.06
Q2'24
Beat
by $0.05
The last earnings report on May 06 showed earnings per share of -43 cents, beating the estimate of -49 cents. With 191.97K shares outstanding, the current market capitalization sits at 56.50M.